Amgen Travel, Research & Preceptorship/Mentorship Program
Program Charter
Overview
The purpose of this charter is to provide details about the Amgen Nephrology Research Grants program, and to provide information about the application administration and review process.
Aims of the Program
The aims of the Amgen Canada Travel, Research and Preceptorship/Mentorship Grants Program are to advance patient care and to facilitate the professional development of Canadian Nephrology Nurses and Nephrology Technologists. This represents Amgen Canada Inc.’s continued commitment to the Canadian nephrology community.
The goals of the Amgen Canada Travel, Research and Preceptorship/Mentorship Grants
Program are:
• To improve patient care and associated outcomes;
• To build on existing nursing and technological knowledge through facilitation of research, preceptorship/mentorship, and educational opportunities;
• To generate new knowledge that will improve the understanding of renal disease management; and
• To provide a vehicle to inspire nephrology nurses and nephrology technologists to seek new learning opportunities and engage in professional projects.
To achieve these aims, Amgen Canada Inc. will award grants within the following categories:
• International Nursing Conference Travel Grant
• Nursing Research Project Grant – Novice Researcher (minor project)
• Nursing Research Project Grant – Experienced Researcher (major project)
• Preceptorship/Mentorship Grant – Nurse Practitioner
• Preceptorship/Mentorship Grant – Vascular Access Nurse
• Preceptorship/Mentorship Grant – Nursing Outreach
• Nephrology Technological Practice Grant
Funding
A total of $19,000 is available in 2010.
The funds will be allocated as follows:
I. International Nursing Conference Travel Grant; $3,000
II. Nursing Research Project Grant – Novice Researcher (minor project); $2,000
III. Nursing Research Project Grant – Experienced Researcher (major project); $4,000
IV. Preceptorship/Mentorship Grant – Nurse Practitioner; $3,000
V. Preceptorship/Mentorship Grant – Vascular Access Nurse; $3,000
VI. Preceptorship/Mentorship Grant – Nursing Outreach; $2,000
VII. Nephrology Technological Practice Grant; $2,000
Administration
A Grant Review Committee (GRC) will be composed of CANNT executive members including current President, President Elect, VP Technology, and a nephrology nurse with Doctorate preparation, as well as Amgen Staff (Medical Director) with experience in nephrology, nephrology clinical trials and medical research. This group will review, evaluate and rank all applications and will have full responsibility for determining grant recipients.
The Application Process
Applicants will complete and submit the following:
1. Cover Letter
2. Completed application form with required signatures
3. Letter of reference from manager
4. Resume or CV
5. Written summary outlining objectives for use of this funding (500 words for International Nursing Conference Travel, Nursing Preceptorship/Mentorship, Technological and Nursing Research (Novice Research) grants; 1000 words for proposal for Nursing Research (Experienced Researcher) grants
6. Signed Release of Personal Information Form
Completed applications will be reviewed by all GRC members (subject to declaration of a conflict of interest – see below). Each member will score the application according to the review criteria guidelines on a standardized scoring sheet.
Please see the “Grant Review Assessment Committee” for further details about the scoring system.
Using the scores from all reviewers, an overall score will be created. Based on this overall score the applications will be ranked. The decision of the GRC will be final.
Potential conflicts of interest
The GRC committee will make every attempt to ensure a fair review for all applications.
Therefore, the GRC members will be asked to declare any conflict of interest and not review applications where the following applies:
• Direct or potential involvement due to a personal financial interest in the outcome of the granting process; and/or potential involvement as a research, or departmental/institutional colleague
Timelines for the review process
• Applications available via CANNT website by March 1st of the granting year
• Application closing date will be May 1st of the granting year
• GRC final decisions will be communicated during the month of September of the granting year
• Recipients will be awarded their grants at the CANNT AGM
Notification Process
Applicants will be notified of the GRC decision by mail by the date outlined above.
Unsuccessful applicants will be invited to contact a GRC member for feedback related to their grant application and are encouraged to do so.
Privacy
All members of the GRC, staff assisting the committee, and Amgen Canada employees shall treat all applications in confidence. Applications will be reproduced for purposes of review and program administration only. Information comprising the names of successful applicants, their institutions, and/or titles of their research projects, the grant awarded and amount of that grant will be disclosed at the CANNT AGM annually and may be published in an Amgen Nephrology Research Grants brochure, public relations literature and/or other documents for general distribution. Applicants will be required to sign a release of personal information disclaimer as part of the application process.
Please direct all inquiries to the following Amgen Canada representative:
Sandy Salter
Product and CHE Senior Manager Nephrology
AMGEN Canada Inc.
6775 Financial Drive, Suite 100
Mississauga, Ontario
Canada L5N 0A4
Direct (905) 285 3330
Cell: (416) 209-9305
Email: ssalter@amgen.com